Impact of COVID-19 infection on patients admitted with nonvariceal upper gastrointestinal bleeding : an analysis from the National Inpatient Sample
Copyright © 2023 Baylor University Medical Center..
Background: Nonvariceal upper gastrointestinal bleeding (NVUGIB) is a medical emergency that has significant morbidity and mortality. The available data about the impact of COVID-19 infection on mortality in patients with NVUGIB is limited.
Methods: We identified all hospitalizations with a principal diagnosis of NVUGIB in 2020. The baseline characteristics and clinical outcomes of patients with COVID-19 infection were compared to those without COVID-19 infection.
Results: NVUGIB patients with COVID-19 infection had higher mortality (5% vs 2%, P < 0.0001), a longer mean length of stay (6.85 vs 4.48 days, P < 0.0001), and a lower rate of esophagogastroduodenoscopy utilization (40% vs 51%, P < 0.0001) than those without COVID-19 infection. Multivariate logistic regression analysis showed that COVID-19 infection was associated with a higher mortality rate (odds ratio 2.2, 95% confidence interval, 1.4-3.4).
Conclusions: COVID-19 infection is an independent predictor of mortality in adults hospitalized with NVUGIB.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Proceedings (Baylor University. Medical Center) - 37(2024), 1 vom: 08., Seite 36-41 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Elfert, Khaled [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 05.01.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1080/08998280.2023.2260280 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366646222 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366646222 | ||
| 003 | DE-627 | ||
| 005 | 20240108142332.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/08998280.2023.2260280 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1249.xml |
| 035 | |a (DE-627)NLM366646222 | ||
| 035 | |a (NLM)38174004 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Elfert, Khaled |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of COVID-19 infection on patients admitted with nonvariceal upper gastrointestinal bleeding |b an analysis from the National Inpatient Sample |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 05.01.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2023 Baylor University Medical Center. | ||
| 520 | |a Background: Nonvariceal upper gastrointestinal bleeding (NVUGIB) is a medical emergency that has significant morbidity and mortality. The available data about the impact of COVID-19 infection on mortality in patients with NVUGIB is limited | ||
| 520 | |a Methods: We identified all hospitalizations with a principal diagnosis of NVUGIB in 2020. The baseline characteristics and clinical outcomes of patients with COVID-19 infection were compared to those without COVID-19 infection | ||
| 520 | |a Results: NVUGIB patients with COVID-19 infection had higher mortality (5% vs 2%, P < 0.0001), a longer mean length of stay (6.85 vs 4.48 days, P < 0.0001), and a lower rate of esophagogastroduodenoscopy utilization (40% vs 51%, P < 0.0001) than those without COVID-19 infection. Multivariate logistic regression analysis showed that COVID-19 infection was associated with a higher mortality rate (odds ratio 2.2, 95% confidence interval, 1.4-3.4) | ||
| 520 | |a Conclusions: COVID-19 infection is an independent predictor of mortality in adults hospitalized with NVUGIB | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a upper gastrointestinal bleeding | |
| 700 | 1 | |a Malik, Mushrin |e verfasserin |4 aut | |
| 700 | 1 | |a Aboursheid, Tarek |e verfasserin |4 aut | |
| 700 | 1 | |a Mohamed, Mouhand |e verfasserin |4 aut | |
| 700 | 1 | |a Elfert, Yomna |e verfasserin |4 aut | |
| 700 | 1 | |a Beran, Azizullah |e verfasserin |4 aut | |
| 700 | 1 | |a Jaber, Fouad |e verfasserin |4 aut | |
| 700 | 1 | |a Elromisy, Esraa |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Taee, Ahmad |e verfasserin |4 aut | |
| 700 | 1 | |a Kahaleh, Michel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Proceedings (Baylor University. Medical Center) |d 2000 |g 37(2024), 1 vom: 08., Seite 36-41 |w (DE-627)NLM158116852 |x 0899-8280 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2024 |g number:1 |g day:08 |g pages:36-41 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/08998280.2023.2260280 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2024 |e 1 |b 08 |h 36-41 | ||